
Management Change2 Nov 2026, 05:41 pm
Akums Drugs Designates Sanjay Kumar as Senior Management Personnel
AI Summary
Akums Drugs and Pharmaceuticals Limited announced that its Board of Directors has approved the designation of Mr. Sanjay Kumar, President – Operations, as Senior Management Personnel. This decision was made based on the recommendation of the Nomination & Remuneration Committee. The company also disclosed its unaudited financial results for the quarter and half-year ended September 30, 2026, along with the limited review reports. Additionally, it was noted that 100% of the Initial Public Offer proceeds have been fully utilized, negating the need for future deviation statements.
Key Highlights
- Sanjay Kumar appointed as Senior Management Personnel.
- Board approved designation based on committee recommendation.
- Unaudited financial results for Q2 FY27 declared.
- IPO proceeds fully utilized.
- No further deviation statements required.
Price Impact
More from AKUMS